Primary Health Properties (PHP) Aktienübersicht
Primary Health Properties Plc (PHP) ist ein britischer Real Estate Investment Trust und führender Investor in moderne Gesundheitsimmobilien. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 2/6 |
| Vergangene Leistung | 2/6 |
| Finanzielle Gesundheit | 0/6 |
| Dividenden | 6/6 |
Belohnungen
Risikoanalyse
PHP Community Fair Values
Create NarrativeSee what 88 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Primary Health Properties Plc Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | UK£0.95 |
| 52-Wochen-Hoch | UK£1.10 |
| 52-Wochen-Tief | UK£0.87 |
| Beta | 0.79 |
| 1 Monat Veränderung | 0.48% |
| 3 Monate Veränderung | 1.33% |
| 1 Jahr Veränderung | 1.23% |
| 3 Jahre Veränderung | 4.05% |
| 5 Jahre Veränderung | -42.66% |
| Veränderung seit IPO | 268.74% |
Aktuelle Nachrichten und Updates
Narrative-Update • Jun 22
PHP: Recent Bullish Coverage Will Support Re Rating Potential Ahead
Analysts have nudged their price target on Primary Health Properties higher to £1.05 per share. This reflects a slightly lower discount rate and updated assumptions around long term profitability and P/E expectations following recent research coverage.Narrative-Update • Jun 06
PHP: Bullish Research Support Will Drive Re Rating Potential Ahead
Analysts have nudged their fair value estimate for Primary Health Properties slightly lower to about £1.15, while backing higher revenue growth assumptions and a modestly higher future P/E. This view is supported by recent price target increases from £1.04 to £1.05 and a new positive initiation from Kepler Cheuvreux.Recent updates
Narrative-Update • Jun 22
PHP: Recent Bullish Coverage Will Support Re Rating Potential Ahead
Analysts have nudged their price target on Primary Health Properties higher to £1.05 per share. This reflects a slightly lower discount rate and updated assumptions around long term profitability and P/E expectations following recent research coverage.Narrative-Update • Jun 06
PHP: Bullish Research Support Will Drive Re Rating Potential Ahead
Analysts have nudged their fair value estimate for Primary Health Properties slightly lower to about £1.15, while backing higher revenue growth assumptions and a modestly higher future P/E. This view is supported by recent price target increases from £1.04 to £1.05 and a new positive initiation from Kepler Cheuvreux.Narrative-Update • Apr 25
PHP: Updated Research And Higher Price Views Will Support Future Upside
Analysts have nudged their price target for Primary Health Properties higher to £1.05, reflecting updated views on discount rates, revenue growth expectations, profit margins and future P/E multiples informed by recent research. Analyst Commentary Bullish Takeaways Bullish analysts point to the revised £1.05 price target as recognition that recent research supports a higher valuation ceiling for Primary Health Properties compared with prior expectations.Narrative-Update • Apr 10
PHP: Higher 2026 Dividend Track Record Will Support Future Upside
The analyst price target for Primary Health Properties has increased from £1.14 to £1.15, with analysts citing refreshed fair value estimates and updated P/E assumptions following recent price target lifts from major banks. Analyst Commentary Recent research updates, including a higher price target of 105 GBp at JPMorgan and a 1 GBp uplift elsewhere, give a window into how the Street is recalibrating its view of Primary Health Properties.Narrative-Update • Mar 27
PHP: Higher 2026 Dividend And Richer P/E Framework Will Support Upside
Analysts have raised their price target on Primary Health Properties by £0.01, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the £0.01 price target uplift as a reflection of refreshed fair value assumptions that better align the shares with current expectations for the portfolio and balance sheet.Narrative-Update • Mar 10
PHP: Rising 2026 Dividend And Steady Metrics Will Support Bullish Outlook
Analysts have kept their £1.14 price target for Primary Health Properties unchanged, citing only very small adjustments to the discount rate and future P/E assumptions that do not materially alter their overall valuation view. What's in the News Primary Health Properties announced a first quarterly interim dividend for 2026 of 1.825 pence per ordinary share, equivalent to 7.3 pence on an annualised basis, compared with 7.1 pence distributed in 2025, which the company describes as a 2.8% increase (Key Developments).Narrative-Update • Feb 24
PHP: Steady Fair Value And 2026 Dividend Will Support Balanced Outlook
Analysts have kept their price target for Primary Health Properties steady at £1.14, with only minor adjustments to inputs such as discount rate, revenue growth, profit margin, and future P/E contributing to an unchanged overall valuation view. What's in the News Primary Health Properties announced the first quarterly interim dividend in 2026 of 1.825 pence per ordinary share, equivalent to 7.3 pence on an annualised basis, with payment scheduled for 13 March 2026 to shareholders on the register on 30 January 2026 (Key Developments).Narrative-Update • Feb 08
PHP: Higher 2026 Dividend And Slightly Richer Multiple Will Support Steady Outlook
Analysts have raised their price target for Primary Health Properties from €1.13 to €1.14, reflecting updated assumptions that include slightly higher revenue, a marginally higher discount rate, a stable profit margin profile and a modestly higher future P/E multiple. What's in the News Primary Health Properties declared the first quarterly interim dividend for 2026 of 1.825 pence per ordinary share, equivalent to 7.3 pence on an annualised basis (Key Developments).Narrative-Update • Jan 25
PHP: Dividend Progress And Slightly Higher Multiple Will Support Steady Outlook
Analysts have nudged their price target for Primary Health Properties higher to reflect a slightly higher fair value estimate, a marginally lower discount rate, and a modestly adjusted future P/E assumption, with only minor changes to projected revenue growth and profit margin inputs. What's in the News Announced a first quarterly interim dividend for 2026 of 1.825 pence per ordinary share, equivalent to 7.3 pence on an annualised basis (Key Developments).Narrative-Update • Jan 08
PHP: Stable Assumptions Will Sustain Earnings Accretion And Funding Cost Benefits
Analysts have kept their fair value estimate for Primary Health Properties broadly steady at £1.11 per share, attributing the unchanged price target to relatively stable assumptions around the discount rate, revenue growth, profit margin and future P/E. Valuation Changes The fair value estimate is held steady at £1.11 per share, reflecting no change in the core valuation outcome.Narrative-Update • Dec 15
PHP: Assura Synergies Will Drive Earnings Accretion And Lower Funding Costs
Analysts have nudged their price target for Primary Health Properties up to £1.10 per share, reflecting expectations that the Assura acquisition will enhance earnings through scale-driven synergies and a lower cost of capital. Analyst Commentary Analysts’ reactions to the Assura acquisition have been broadly positive, with focus on the enlarged platform’s earnings profile, financing benefits, and integration execution risks.Narrative-Update • Nov 27
PHP: Assura Integration Will Drive Earnings Accretion Through Cost Synergies
Analysts have modestly raised their price target for Primary Health Properties to £1.10 per share, citing anticipated operational synergies and an improved earnings outlook following the Assura acquisition. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the acquisition of Assura is expected to bring increased scale and recurring income to Primary Health Properties, strengthening its market position.Narrative-Update • Nov 13
PHP: Anticipated Assura Integration Will Drive Accretive Earnings And Cost Synergies
Analysts have raised their price target on Primary Health Properties from £1.08 to £1.11, citing anticipated earnings accretion and operational synergies following the Assura acquisition. Analyst Commentary Bullish Takeaways Bullish analysts highlight the anticipated earnings accretion driven by the integration of Assura, which is expected to position the company for improved profitability.Narrative-Update • Oct 29
10-Year NHS Plan Will Modernize UK Primary Care Sites
Analysts have raised their price target for Primary Health Properties from £1.07 to £1.08, citing anticipated earnings accretion and synergy benefits following the company's acquisition of Assura. Analyst Commentary Analyst perspectives following the acquisition focus on the expected performance and potential risks for Primary Health Properties as the company integrates Assura.Neues Narrative • Jun 29
10-Year NHS Plan Will Modernize UK Primary Care Sites
Company benefits from government policy shifts, chronic under-supply, and demographic trends, driving opportunities for growth, high occupancy, and resilient earnings.Analyseartikel • Feb 22
Could The Primary Health Properties PLC (LON:PHP) Ownership Structure Tell Us Something Useful?
Every investor in Primary Health Properties PLC ( LON:PHP ) should be aware of the most powerful shareholder groups...Analyseartikel • Jan 07
Shareholders Of Primary Health Properties (LON:PHP) Must Be Happy With Their 79% Return
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...Aktionärsrenditen
| PHP | GB Health Care REITs | GB Markt | |
|---|---|---|---|
| 7D | -0.2% | -1.0% | -1.2% |
| 1Y | 1.2% | 3.9% | 16.6% |
Rendite im Vergleich zur Industrie: PHP unter dem Niveau der Branche UK Health Care REITs , die im vergangenen Jahr eine Rendite von 3.9% erzielte.
Rendite vs. Markt: PHP hinter dem Markt UK zurück, der im vergangenen Jahr eine Rendite von 16.6 erzielte.
Preisvolatilität
| PHP volatility | |
|---|---|
| PHP Average Weekly Movement | 2.3% |
| Health Care REITs Industry Average Movement | 2.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stabiler Aktienkurs: PHP hatte in den letzten 3 Monaten im Vergleich zum UK -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: PHPDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1994 | 156 | Mark Anthony Davies | www.phpgroup.co.uk |
Primary Health Properties Plc (PHP) ist ein britischer Real Estate Investment Trust und führender Investor in moderne Gebäude der medizinischen Grundversorgung. Wir investieren in flexible, moderne Immobilien für die lokale medizinische Grundversorgung. Das übergeordnete Ziel der Gruppe ist die Erwirtschaftung progressiver Renditen für die Aktionäre durch eine Kombination aus Ertragswachstum und Kapitalzuwachs.
Primary Health Properties Plc's Grundlagenzusammenfassung
| PHP grundlegende Statistiken | |
|---|---|
| Marktanteil | UK£2.46b |
| Gewinn(TTM) | UK£159.00m |
| Umsatz(TTM) | UK£367.00m |
15.5x
Kurs-Gewinn-Verhältnis 6.7x
Kurs-Umsatz-VerhältnisIst PHP zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| PHP Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | UK£367.00m |
| Kosten der Einnahmen | UK£37.00m |
| Bruttogewinn | UK£330.00m |
| Sonstige Ausgaben | UK£171.00m |
| Gewinn | UK£159.00m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 0.061 |
| Bruttomarge | 89.92% |
| Nettogewinnspanne | 43.32% |
| Schulden/Eigenkapital-Verhältnis | 130.7% |
Wie hat sich PHP auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
7.7%
Aktuelle Dividendenrendite65%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/19 20:30 |
| Aktienkurs zum Tagesende | 2026/08/19 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Primary Health Properties Plc wird von 16 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Kanad Mitra | Barclays |
| Thomas Musson | Berenberg |
| Christopher Millington | Deutsche Bank |